Professor David O Cosgrove

Publications


Journals

  • Lim AK; Patel N; Eckersley RJ; Fitzpatrick J; Crossey MM; Hamilton G; Goldin RD; Thomas HC; et alVennart W; Cosgrove DO; Taylor-Robinson SD. (Oct 2011). A comparison of 31P magnetic resonance spectroscopy and microbubble-enhanced ultrasound for characterizing hepatitis c-related liver disease. J Viral Hepat. 18:e530-e534. DOI.
  • Cosgrove DO. (Dec 2010). Contrast-enhanced ultrasound of liver lesions. Ultrasound Med Biol. 36:2146. DOI.
  • Sorelli PG; Cosgrove DO; Svensson WE; Zaman N; Satchithananda K; Barrett NK; Lim AK. (May 2010). Can contrast-enhanced sonography distinguish benign from malignant breast masses?. J Clin Ultrasound. 38:177-181. DOI.
  • Lim AK; Patel N; Eckersley RJ; Cobbold JF; Crossey MM; Cosgrove DO; Goldin RD; Thomas HC; et alTaylor-Robinson SD. (Nov 2010). Hepatic vein transit times of a microbubble agent in assessing response to antiviral treatment in patients with chronic hepatitis C. J Viral Hepat. 17:778-783. DOI.
  • Grier S; Patel N; Kuo YT; Cosgrove DO; Goldin RC; Thomas HC; Taylor-Robinson SD; Lim AK. (Mar 2010). Perihepatic lymph nodes as markers of disease response in patients with hepatitis C-related liver disease: a prospective clinical evaluation. Eur J Gastroenterol Hepatol. 22:257-263. DOI.
  • Cosgrove DO; Chan KE. (Jun 2008). Renal transplants: what ultrasound can and cannot do. Ultrasound Q. 24:77-87. DOI.
  • Ellis SM; Naoumova RP; Neuwirth CK; Eckersley R; Cosgrove DO; Thompson GR; Sidhu PS. (1 Jul 2007). Measurement of the reflectivity of the intima-medial layer of the common carotid artery improves the discriminatory value of intima-medial thickness measurement as a predictor of risk of atherosclerotic disease. ULTRASOUND IN MEDICINE AND BIOLOGY. 33:1029-1038. Author weblink DOI.
  • Cosgrove DO. (Jan 2007). A revolution in liver ultrasound. Eur J Gastroenterol Hepatol. 19:1-2. DOI.
  • Lim AK; Patel N; Eckersley RJ; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; Blomley MJ. (Jul 2006). Hepatic vein transit time of SonoVue: a comparative study with Levovist. Radiology. 240:130-135. DOI.
  • Espahbodi S; Humphries KN; Doré CJ; McCarthy ID; Standfield NJ; Cosgrove DO; Hughes SP. (Feb 2006). Colour doppler ultrasound of the lumbar arteries: a novel application and reproducibility study in healthy subjects. Ultrasound Med Biol. 32:171-182. DOI.
  • Sidhu PS; Allan PL; Cattin F; Cosgrove DO; Davies AH; Do DD; Karakagil S; Langholz J; et alLegemate DA; Martegani A; Llull JB; Pezzoli C; Spinazzi A. (1 Jan 2006). Diagnostic efficacy of SonoVue (R), a second generation contrast agent, in the assessment of extracranial carotid or peripheral arteries using colour and spectral Doppler ultrasound: a multicentre study. BRITISH JOURNAL OF RADIOLOGY. 79:44-51. Author weblink DOI.
  • Taylor PC; Steuer A; Gruber J; McClinton C; Cosgrove DO; Blomley MJ; Marsters PA; Wagner CL; et alMaini RN. (Jan 2006). Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. Arthritis Rheum. 54:47-53. DOI.
  • Padhani AR; Harvey CJ; Cosgrove DO. (1 Dec 2005). Angiogenesis imaging in the management of prostate cancer. NATURE CLINICAL PRACTICE UROLOGY. 2:596-607. Author weblink DOI.
  • Lim AK; Patel N; Eckersley RJ; Kuo YT; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; et alBlomley MJ. (Jun 2005). Can Doppler sonography grade the severity of hepatitis C-related liver disease?. AJR Am J Roentgenol. 184:1848-1853.
  • Marshall M; Halligan S; Eckersley RJ; Williams A; Blomley MJK; Cosgrove DO; Bartram CI. (1 Feb 2005). A novel technique to measure splanchnic transit time using microbubble ultrasound. INVESTIGATIVE RADIOLOGY. 40:80-84. Author weblink DOI.
  • Lim AK; Taylor-Robinson SD; Patel N; Eckersley RJ; Goldin RD; Hamilton G; Foster GR; Thomas HC; et alCosgrove DO; Blomley MJ. (Jan 2005). Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut. 54:128-133. DOI.
  • Liang HD; Lu QL; Xue SA; Halliwell M; Kodama T; Cosgrove DO; Stauss HJ; Partridge TA; et alBlomley MJ. (Nov 2004). Optimisation of ultrasound-mediated gene transfer (sonoporation) in skeletal muscle cells. Ultrasound Med Biol. 30:1523-1529. DOI.
  • Bryant TH; Blomley MJ; Albrecht T; Sidhu PS; Leen EL; Basilico R; Pilcher JM; Bushby LH; et alHoffmann CW; Harvey CJ; Lynch M; MacQuarrie J; Paul D; Cosgrove DO. (Sep 2004). Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology. 232:799-809. DOI.
  • Lim AK; Patel N; Eckersley RJ; Taylor-Robinson SD; Cosgrove DO; Blomley MJ. (Jun 2004). Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers. Radiology. 231:785-788. DOI.
  • D'Arcy TJ; Jayaram V; Lynch M; Soutter WP; Cosgrove DO; Harvey CJ; Patel N. (Jun 2004). Ovarian cancer detected non-invasively by contrast-enhanced power Doppler ultrasound. BJOG. 111:619-622. DOI.
  • Taylor PC; Steuer A; Gruber J; Cosgrove DO; Blomley MJ; Marsters PA; Wagner CL; McClinton C; et alMaini RN. (Apr 2004). Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheum. 50:1107-1116. DOI.
  • Blomley MJ; Lim AK; Harvey CJ; Patel N; Eckersley RJ; Basilico R; Heckemann R; Urbank A; et alCosgrove DO; Taylor-Robinson SD. (Aug 2003). Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study. Gut. 52:1188-1193.
  • Albrecht T; Blomley MJK; Burns PN; Wilson S; Harvey CJ; Leen E; Claudon M; Calliada F; et alCorreas JM; LaFortune M; Campani R; Hoffmann CW; Cosgrove DO; LeFevre F. (May 2003). Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: Multicenter study. RADIOLOGY. 227:361-370.
  • Harvey CJ; Lim AK; Blomley MJ; Taylor-Robinson SD; Gedroyc WM; Cosgrove DO. (Dec 2002). Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles. Eur Radiol. 12 Suppl 3:S70-S73. DOI.
  • Okada M; Albrecht T; Blomley MJ; Heckemann RA; Cosgrove DO; Wolf KJ. (Aug 2002). Heterogeneous delayed enhancement of the liver after ultrasound contrast agent injection--a normal variant. Ultrasound Med Biol. 28:1089-1092.
  • Basilico R; Blomley MJK; Cosgrove DO; Llull JB; Broillet A; Bauer A; Bonomo L. (1 Aug 2002). The first phase I study of a novel ultrasound contrast agent (BR14): Assessment of safety and efficacy in liver and kidneys. ACADEMIC RADIOLOGY. 9:S380-S381. Author weblink DOI.
  • Eckersley RJ; Sedelaar JP; Blomley MJ; Wijkstra H; deSouza NM; Cosgrove DO; de la Rosette JJ. (1 Jun 2002). Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate. 51:256-267. DOI.
  • Bauer A; Becher H; Blomley M; Borges A; Cosgrove D; Leen E; Schlief R; Tiemann K. (May 2002). Ultrasonic imaging of organ perfusion with SH U 563A. Acad Radiol. 9 Suppl 1:S46-S51.
  • Lim AKP; Patel N; Hamilton G; Blomley MJK; Cosgrove DO; Foster GR; Goldin RD; Thomas HC; et alTaylor-Robinson SD. (1 Apr 2002). A prospective assessment of hepatic vein transit times using microbubble-enhanced ultrasound in non-invasive grading of hepatitis C (HCV) related liver disease. GUT. 50:A53-A53. Author weblink.
  • Harvey CJ; Pilcher JM; Eckersley RJ; Blomley MJ; Cosgrove DO. (Mar 2002). Advances in ultrasound. Clin Radiol. 57:157-177. DOI.
  • Heckemann RA; Harvey CJ; Blomley MJ; Eckersley RJ; Butler-Barnes J; Jayaram V; Cosgrove DO. (Mar 2002). Enhancement characteristics of the microbubble agent Levovist: reproducibility and interaction with aspirin. Eur J Radiol. 41:179-183.
  • Quaia E; Blomley MJ; Patel S; Harvey CJ; Padhani A; Price P; Cosgrove DO. (Mar 2002). Initial observations on the effect of irradiation on the liver-specific uptake of Levovist. Eur J Radiol. 41:192-199.
  • Basilico R; Blomley MJ; Harvey CJ; Filippone A; Heckemann RA; Eckersley RJ; Cosgrove DO. (Mar 2002). Which continuous US scanning mode is optimal for the detection of vascularity in liver lesions when enhanced with a second generation contrast agent?. Eur J Radiol. 41:184-191.
  • Bamber JC; Barbone PE; Bush NL; Cosgrove DO; Doyely MM; Fuechsel FG; Meaney PM; Miller NR; et alShiina T; Tranquart F. (1 Jan 2002). Progress in freehand elastography of the breast. IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS. E85D:5-14. Author weblink.
  • Welsh AW; Taylor MJ; Cosgrove D; Fisk NM. (Oct 2001). Freehand three-dimensional Doppler demonstration of monochorionic vascular anastomoses in vivo: a preliminary report. Ultrasound Obstet Gynecol. 18:317-324. DOI.
  • Welsh AW; Humphries K; Cosgrove DO; Taylor MJ; Fisk NM. (Sep 2001). Development of three-dimensional power Doppler ultrasound imaging of fetoplacental vasculature. Ultrasound Med Biol. 27:1161-1170.
  • Blomley MJ; Sidhu PS; Cosgrove DO; Albrecht T; Harvey CJ; Heckemann RA; Butler-Barnes J; Eckersley RJ; et alBasilico R. (Sep 2001). Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience. Radiology. 220:661-667.
  • Blomley MJ; Cooke JC; Unger EC; Monaghan MJ; Cosgrove DO. (19 May 2001). Microbubble contrast agents: a new era in ultrasound. BMJ. 322:1222-1225.
  • Blomley MJK; Cooke JC; Unger EC; Monaghan MJ; Cosgrove DO. (19 May 2001). Science, medicine, and the future - Microbubble contrast agents: a new era in ultrasound. BRITISH MEDICAL JOURNAL. 322:1222-1225. Author weblink DOI.
  • Patel N; Blomley MJ; Cosgrove DO; Harvey CJ; Thomas HC; Taylor-Robinson SD. (1 Apr 2001). Liver vascular transit times measured after ultrasound contrast injection: A measure of diffuse liver disease?. JOURNAL OF HEPATOLOGY. 34:225-225. Author weblink DOI.
  • Harvey CJ; Blomley MJ; Eckersley RJ; Cosgrove DO. (2001). Developments in ultrasound contrast media. Eur Radiol. 11:675-689.
  • Albrecht T; Cosgrove DO; Butler-Barnes J; Jayaram V; Mahler M; Urbank A; Bauer A. (1 Oct 2000). Comparison of bolus and infusion of the ultrasound contrast agent Levovist fur colour Doppler ultrasound of renal arteries. ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN. 172:824-829. Author weblink DOI.
  • Harvey CJ; Blomley MJ; Eckersley RJ; Cosgrove DO; Patel N; Heckemann RA; Butler-Barnes J. (Sep 2000). Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SH U 508A-early experience. Radiology. 216:903-908.
  • Heckemann RA; Cosgrove DO; Blomley MJ; Eckersley RJ; Harvey CJ; Mine Y. (Aug 2000). Liver lesions: intermittent second-harmonic gray-scale US can increase conspicuity with microbubble contrast material-early experience. Radiology. 216:592-596.
  • Cosgrove DO; Kiely P; Williamson R; Blomley MJ; Eckersley RJ. (Jul 2000). Ultrasonographic contrast media in the urinary tract. BJU Int. 86 Suppl 1:11-17.
  • Georgian-Smith D; Taylor KJW; Madjar H; Goldberg B; Merritt CRB; Bokobsa J; Rubin E; Mendelson EB; et alFornage BD; Rouse G; Wadden NAT; Dewbury KC; Cosgrove DO; Schmidt R. (1 Jun 2000). Sonography of palpable breast cancer. JOURNAL OF CLINICAL ULTRASOUND. 28:211-216. Author weblink DOI.
  • Cosgrove DO; Eckersley RJ. (May 2000). Breast. Ultrasound Med Biol. 26 Suppl 1:S110-S115.
  • Denbow ML; Eckersley R; Welsh AW; Taylor MJ; Carter RC; Cosgrove DO; Fisk NM. (Apr 2000). Ex vivo delineation of placental angioarchitecture with the microbubble contrast agent Levovist. Am J Obstet Gynecol. 182:966-971.
  • Harvey CJ; Blomley MJK; Eckersley RJ; Heckemann RA; Butler-Barnes J; Cosgrove DO. (4 Mar 2000). Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases. LANCET. 355:807-808. Author weblink DOI.
  • Denbow ML; Welsh AW; Taylor MJ; Blomley MJ; Cosgrove DO; Fisk NM. (Mar 2000). Twin fetuses: intravascular microbubble US contrast agent administration--early experience. Radiology. 214:724-728.
  • Albrecht T; Blomley MJK; Heckemann RA; Cosgrove DO; Jayaram V; Butler-Barnes J; Eckersley RJ; Hoffmann CW; et alBauer A. (1 Jan 2000). Stimulated acoustic emission with the ultrasound contrast agent levovist: a clinically useful contrast effect with liver-specific properties. ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN. 172:61-67. Author weblink DOI.
  • Blomley MJ; Albrecht T; Cosgrove DO; Eckersley RJ; Butler-Barnes J; Jayaram V; Patel N; Heckemann RA; et alBauer A; Schlief R. (Nov 1999). Stimulated acoustic emission to image a late liver and spleen-specific phase of Levovist in normal volunteers and patients with and without liver disease. Ultrasound Med Biol. 25:1341-1352.
  • Albrecht T; Blomley MJ; Cosgrove DO; Taylor-Robinson SD; Jayaram V; Eckersley R; Urbank A; Butler-Barnes J; et alPatel N. (8 May 1999). Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet. 353:1579-1583. DOI.
  • Albrecht T; Blomley MJK; Cosgrove DO; Taylor-Robinson SD; Jayaram V; Eckersley R; Urbank A; Butler-Barnes J; et alPatel N. (1 Jan 1999). Transit-time studies with Levovist in patients with and without hepatic cirrhosis: A promising new diagnostic tool. EUROPEAN RADIOLOGY. 9:S377-S381. Author weblink DOI.
  • Blomley MJ; Albrecht T; Cosgrove DO; Patel N; Jayaram V; Butler-Barnes J; Eckersley RJ; Bauer A; et alSchlief R. (Feb 1999). Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience. Radiology. 210:409-416.
  • Blomley MJ; Albrecht T; Cosgrove DO; Jayaram V; Eckersley RJ; Patel N; Taylor-Robinson S; Bauer A; et alSchlief R. (Dec 1998). Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of an US contrast agent: early experience in seven patients with metastases. Radiology. 209:862-866.
  • Blomley MJ; Albrecht T; Taylor-Robinson S; Cosgrove DO. (1 Oct 1998). Liver vascular transit analysed using bolus injections of an ultrasound contrast agent: A novel test for cirrhosis. HEPATOLOGY. 28:240A-240A. Author weblink.
  • Blomley MJ; Albrecht T; Taylor-Robinson S; Cosgrove DO. (1 Oct 1998). Liver vascular transit analysed using bolus injections of an ultrasound contrast agent: Does it help in imaging focal liver lesions?. HEPATOLOGY. 28:754A-754A. Author weblink.
  • Blomley MJ; Albrecht T; Taylor-Robinson S; Cosgrove DO; Eckersley RJ; Jayaram V; Butler-Barnes J; Patel N; et alHeckemann RA. (1 Oct 1998). Stimulated acoustic imaging in the liver parenchyma after microbubble enhancement can improve the conspicuity of liver metastases with ultrasound. HEPATOLOGY. 28:754A-754A. Author weblink.
  • Albrecht T; Urbank A; Mahler M; Bauer A; Doré CJ; Blomley MJ; Cosgrove DO; Schlief R. (May 1998). Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience. Radiology. 207:339-347.
  • Albrecht T; Patel N; Cosgrove DO; Jayaram V; Blomley MJK; Eckersley R. (1 Apr 1998). Enhancement of power Doppler signals from breast lesions with the ultrasound contrast agent EchoGen emulsion: Subjective and quantitative assessment. ACADEMIC RADIOLOGY. 5:S195-S198. Author weblink DOI.
  • Blomley MJ; Ramsey CM; Cosgrove DO; Patel N; Lynch M; Glass DM; Peters AM. (Oct 1997). The ureteric jet index: a novel measure of divided renal function. Clin Radiol. 52:771-774.
  • Blomley MJK; Albrecht T; Cosgrove DO; Bamber JC. (1 Jul 1997). Can relative contrast agent concentration be measured in vivo with color Doppler US?. RADIOLOGY. 204:279-280. Author weblink.
  • Albrecht T; Lotzof K; Hussain HK; Shedden D; Cosgrove DO; de Bruyn R. (Apr 1997). Power Doppler US of the normal prepubertal testis: does it live up to its promises?. Radiology. 203:227-231.
  • Sidhu PS; Jonker ND; Khaw KT; Patel N; Blomley MJ; Chaudhuri KR; Frackowiak RS; Cosgrove DO. (Jan 1997). Spontaneous dissections of the internal carotid artery: appearances on colour Doppler ultrasound. Br J Radiol. 70:50-57.
  • Cosgrove DO; Blomley MJ. (Sep 1996). Do benefits of contrast outweigh its costs?. Diagn Imaging (San Franc). Suppl:AU31-AU32.
  • Albrecht T; Cosgrove DO; Correas JM; Rallidis L; Nihoyanopoulos P; Patel N. (1 Aug 1996). Renal, hepatic, and cardiac enhancement on Doppler and gray-scale sonograms obtained with EchoGen. ACADEMIC RADIOLOGY. 3:S198-S200. Author weblink DOI.
  • MacSweeney JE; Cosgrove DO; Arenson J. (Jun 1996). Colour Doppler energy (power) mode ultrasound. Clin Radiol. 51:387-390.
  • Cockburn JF; Cosgrove DO. (May 1995). Device to enhance visibility of needle or catheter tip at color Doppler US. Radiology. 195:570-572.
  • CRAWFORD DC; COSGROVE DO; TOHNO E; BOSSI C; KEDAR R; BELL DS; KALE S; NORMAN A; et alBAMBER JC. (1 Mar 1995). ADAPTIVE SPECKLE REDUCTION FOR IMPROVING THE DIFFERENTIAL-DIAGNOSIS OF BREAST-LESIONS. JOURNAL OF ULTRASOUND IN MEDICINE. 14:217-227. Author weblink.
  • Jackson DM; Collins CD; Cosgrove DO. (Mar 1995). Case report: diffuse fatty infiltration of the renal parenchyma secondary to bilateral angiomyolipomas--features on ultrasound and computed tomography. Br J Radiol. 68:318-320.
  • COSGROVE DO. (1 Aug 1994). COLOR DOPPLER SIGNALS IN BREAST DISEASES - RESPONSE. RADIOLOGY. 192:580-581. Author weblink.

Chapters in books

  • Sennoga CA; Yeh JS; Seddon JM; Nourshargh S; Eckersley RJ; Haskard DO; Cosgrove DO; Nihoyannopoulos P. Microbulles ciblees pour I'imagerie ultrasonore. In Echographie de Contraste. 321-328. Tranquart F (ed); Correreas J-M (ed); Bouakaz A (ed). Springer, Paris (2007).

Conferences

  • Cosgrove DO; Dore C; Tourasse C; Ohlinger R; Madjar H; Hooley R; Balu-Maestro C; Mendelson E; et alSvensson W; Tardivon A; Cossi A; Barke L; Larsen L. Preliminary assessment of ShearWave (TM) elastography features in predicting breast lesion malignancy. Annual Scientific Meeting of the Royal-College-of-Radiologists-Breast-Group, 31 Oct 2010 - 2 Nov 2010. 12. BIOMED CENTRAL LTD (1 Jan 2010). Author weblink DOI.
  • Cobbold JF; Patel N; Goldin RD; Crossey ME; Morin SH; Fitzpatrick JA; Arridge M; Cox IJ; et alThomas HC; Cosgrove DO; Thursz MR; Leen EL; Taylor-Robinson SD. Early haemodynamic responses to interferon therapy in patients with chronic liver disease using contrast-enhanced ultrasound: Regulation by hepatic stellate cells?. 43rd Annual Meeting of the European-Association-for-the-Study-of-the-Liver. 48:S271-S271. (Feb 2008).
  • Lim AKP; Patel N; Eckersley RJ; Bryant TH; Cosgrove DO; Thomas HC; Blomley MJ; Taylor-Robinson SD. Does microbubble ultrasound help with hepatocellular carcinoma screening in patients with HCV related liver disease?. Annual Meeting of the British-Society-of-Gastroenterology. 53:A79-A79. (Apr 2004).
  • Lim AKP; Harvey CJ; Taylor-Robinson SD; Blomley MJK; Cosgrove DO. Use of ultrasound contrast agents in hepatology. Falk Symposium on Medical Imaging in Gastroenterology and Hepatology, 28 Sep 2001 - 29 Sep 2001. 124:132-139. SPRINGER (1 Jan 2002). Author weblink.
  • Cosgrove DO. Echo-enhancing (ultrasound contrast) agents. 3rd Mayneord-Phillips Summer School, Jun 1997. 225-239. IOP PUBLISHING LTD (1 Jan 1998). Author weblink.
  • Eckersley RJ; Cosgrove DO; Blomley MJ; Hashimoto H. Functional imaging of tissue response to bolus injection of ultrasound contrast agent. 1998 IEEE Ultrasonics Symposium. 1779-1782. (1998).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook